Copenhagen-based HealthTech startup Aisel Health has closed a €1.7 million pre-Seed round to scale its AI-powered operating system for psychiatric care — a platform built to surface the right patient information for clinicians at the right moment and ease the administrative load created by fragmented medical records.
The Round
The pre-Seed round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside returning backers Rockstart and EIFO.
The Problem Aisel Is Solving
Founded in 2024 by Augusta Klingsten Peytz and Christian Houen, Aisel Health builds software that helps psychiatric clinics scale their operations by surfacing the right information for clinicians at the right time.
The company’s core insight is that AI scribes have solved the wrong problem. While AI note-taking tools have eased the burden on overworked clinicians, faster documentation creates a different bottleneck: as notes become cheaper and quicker to produce, the information buried inside them becomes harder to find. With patient records piling up across referrals, prior sessions, and disconnected systems, the real challenge shifts from writing notes to retrieving what matters from them.
Aisel points to its own research, “The Documentation Minute,” which found that psychiatrists spend far longer gathering evidence than actually writing notes — piecing together a patient’s history from referrals, prior notes, and multiple systems before treatment can even begin.
Co-founder and CEO Augusta Klingsten Peytz frames the opportunity in terms of what technology can add to clinical judgment, not replace: the goal is a product built around the realities of psychiatric care, where clinicians bring judgment, empathy, and years of trained intuition, while the technology contributes speed, structure, and the ability to track every relevant detail about a patient in ways human memory alone cannot.
Co-founder and Chief Product Officer Christian Houen points to a system under mounting strain, warning that psychiatric care is approaching a breaking point on waiting lists, and that shortening treatment cycles depends on giving clinicians the accumulated understanding they build across consultations over time.
What the Product Does
Aisel’s platform converts interview recordings, documents, and patient accounts into structured insights that clinicians can access during consultations, effectively briefing a clinician on a patient’s full history — medications, prior episodes, symptom scales, family history — before, during, and after each session.
Per its own materials, the system is designed as an assistive layer rather than a decision-maker: it assembles, cites, and checks the evidence while leaving clinicians to author and sign off on conclusions, and runs on GDPR- and ISO 27001-compliant infrastructure with UK/EU data residency.
What’s Next
Aisel plans to put the fresh capital toward growing its clinical and engineering team and funding its entry into the UK market, converting an active commercial pipeline of private psychiatry providers ahead of a planned Seed round.
The broader market backs the timing: the mental health technology sector is projected to keep expanding quickly as AI adoption and rising demand for psychiatric care push growth, even as patients continue to wait weeks or months for appointments across both private and public systems.
Aisel’s technology is reportedly already active in private psychiatric clinics, with plans for a broader rollout as the company heads toward its Seed round.
